Rate of weight gain (g/kg/day) · patients with preterm infants
1 finding from 1 review
Proportion of infants having at least one episode of low temperature requiring overhead heater use · patients with preterm infants
Transfer from incubator to cot at lower showed no clear difference in proportion of infants having at least one episode of low temperature… compared with higher body weight (high certainty).
1 finding from 1 review
Proportion of infants having at least one episode of returning to incubator · patients with preterm infants
Transfer from incubator to cot at lower showed no clear difference in proportion of infants having at least one episode of returning to… compared with higher body weight (moderate certainty).
1 finding from 1 review
Duration from transfer to cot to discharge home (days) · patients with preterm infants
1 finding from 1 review
Postmenstrual age at discharge · patients with preterm infants
1 finding from 1 review
Length of hospital stay · patients with preterm infants
1 finding from 1 review
Breastfeeding (exclusive at discharge) · patients with preterm infants
Transfer from incubator to cot at lower showed no clear difference in proportion of infants exclusive breastfeeding at discharge compared with higher body weight (high certainty).
1 finding from 1 review
Death or bronchopulmonary dysplasia at 36 weeks PMA · preterm infants at risk for bronchopulmonary dysplasia
Lower showed no clear difference in death or bronchopulmonary dysplasia at 36 weeks PMA compared with higher cumulative dose dexamethasone regimen (low certainty).
1 finding from 1 review
Death or cerebral palsy at 1 to 3 years · preterm infants at risk for bronchopulmonary dysplasia
Lower showed no clear difference in death or cerebral palsy at 1 to 3 years compared with higher cumulative dose dexamethasone regimen (low certainty).
1 finding from 1 review
Death or abnormal neurodevelopmental outcome (various definitions) · preterm infants at risk for bronchopulmonary dysplasia
It is very uncertain whether lower changes death or abnormal neurodevelopmental outcome (various definitions)… compared with higher cumulative dose dexamethasone regimen (very low certainty).
1 finding from 1 review
Underweight · healthy, full‐term (37 to 42 weeks), formula‐fed infants
1 finding from 1 review
Wasting · healthy, full‐term (37 to 42 weeks), formula‐fed infants
1 finding from 1 review
Overweight · healthy, full‐term (37 to 42 weeks), formula‐fed infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Obesity · healthy, full‐term (37 to 42 weeks), formula‐fed infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · healthy, full‐term (37 to 42 weeks), formula‐fed infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · healthy, full‐term (37 to 42 weeks), formula‐fed infants
Standard‐protein formula showed no clear difference in adverse events compared with low‐protein formula (low certainty).
1 finding from 1 review
Stunting · healthy, full‐term (37 to 42 weeks), formula‐fed infants
1 finding from 1 review
Wasting · healthy, full‐term (37 to 42 weeks), formula‐fed infants
1 finding from 1 review
Overweight · healthy, full‐term (37 to 42 weeks), formula‐fed infants
It is very uncertain whether high‐protein formula changes overweight compared with standard‐protein formula (very low certainty).
1 finding from 1 review
Obesity · healthy, full‐term (37 to 42 weeks), formula‐fed infants
It is very uncertain whether high‐protein formula changes obesity compared with standard‐protein formula (very low certainty).
1 finding from 1 review